BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 20674321)

  • 21. Oral Administration of Human Polyvalent IgG by Mouthwash as an Adjunctive Treatment of Chronic Oral Candidiasis.
    Pedraza-Sánchez S; Méndez-León JI; Gonzalez Y; Ventura-Ayala ML; Herrera MT; Lezana-Fernández JL; Bellanti JA; Torres M
    Front Immunol; 2018; 9():2956. PubMed ID: 30627128
    [No Abstract]   [Full Text] [Related]  

  • 22. Chronic Mucocutaneous Candidiasis in Autoimmune Polyendocrine Syndrome Type 1.
    Humbert L; Cornu M; Proust-Lemoine E; Bayry J; Wemeau JL; Vantyghem MC; Sendid B
    Front Immunol; 2018; 9():2570. PubMed ID: 30510552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human inborn errors of immunity underlying superficial or invasive candidiasis.
    Puel A
    Hum Genet; 2020 Jun; 139(6-7):1011-1022. PubMed ID: 32124012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Main human inborn errors of immunity leading to fungal infections.
    Cifaldi C; Ursu GM; D'Alba I; Paccoud O; Danion F; Lanternier F; Chiriaco M
    Clin Microbiol Infect; 2022 Nov; 28(11):1435-1440. PubMed ID: 35863627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic Candidiasis in Children.
    Green L; Dolen WK
    Curr Allergy Asthma Rep; 2017 May; 17(5):31. PubMed ID: 28429308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Candidiasis in patients with APS-1: low IL-17, high IFN-γ, or both?
    Philippot Q; Casanova JL; Puel A
    Curr Opin Immunol; 2021 Oct; 72():318-323. PubMed ID: 34455138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of T-helper cell subsets and cytokines by lymphocytes from patients with chronic mucocutaneous candidiasis.
    Kobrynski LJ; Tanimune L; Kilpatrick L; Campbell DE; Douglas SD
    Clin Diagn Lab Immunol; 1996 Nov; 3(6):740-5. PubMed ID: 8914768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary immunodeficiency and chronic mucocutaneous candidiasis: pathophysiological, diagnostic, and therapeutic approaches.
    Egri N; Esteve-Solé A; Deyà-Martínez À; Ortiz de Landazuri I; Vlagea A; García AP; Cardozo C; Garcia-Vidal C; Bartolomé CS; Español-Rego M; Yiyi L; Bosch-Amate X; Ferrando J; Yagüe J; Juan M; Alsina L
    Allergol Immunopathol (Madr); 2021; 49(1):118-127. PubMed ID: 33528939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pattern recognition receptor expression is not impaired in patients with chronic mucocutanous candidiasis with or without autoimmune polyendocrinopathy candidiasis ectodermal dystrophy.
    Hong M; Ryan KR; Arkwright PD; Gennery AR; Costigan C; Dominguez M; Denning DW; McConnell V; Cant AJ; Abinun M; Spickett GP; Swan DC; Gillespie CS; Young DA; Lilic D
    Clin Exp Immunol; 2009 Apr; 156(1):40-51. PubMed ID: 19196253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [CMCD: Chronic Mucocutaneous Candidiasis Disease].
    Okada S
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(2):109-117. PubMed ID: 28603201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic mucocutaneous candidiasis and connective tissue disorder in humans with impaired JNK1-dependent responses to IL-17A/F and TGF-β.
    Li J; Ritelli M; Ma CS; Rao G; Habib T; Corvilain E; Bougarn S; Cypowyj S; Grodecká L; Lévy R; Béziat V; Shang L; Payne K; Avery DT; Migaud M; Boucherit S; Boughorbel S; Guennoun A; Chrabieh M; Rapaport F; Bigio B; Itan Y; Boisson B; Cormier-Daire V; Syx D; Malfait F; Zoppi N; Abel L; Freiberger T; Dietz HC; Marr N; Tangye SG; Colombi M; Casanova JL; Puel A
    Sci Immunol; 2019 Nov; 4(41):. PubMed ID: 31784499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two novel gain-of-function mutations of STAT1 responsible for chronic mucocutaneous candidiasis disease: impaired production of IL-17A and IL-22, and the presence of anti-IL-17F autoantibody.
    Yamazaki Y; Yamada M; Kawai T; Morio T; Onodera M; Ueki M; Watanabe N; Takada H; Takezaki S; Chida N; Kobayashi I; Ariga T
    J Immunol; 2014 Nov; 193(10):4880-7. PubMed ID: 25288569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defective trained immunity in patients with STAT-1-dependent chronic mucocutaneaous candidiasis.
    Ifrim DC; Quintin J; Meerstein-Kessel L; Plantinga TS; Joosten LA; van der Meer JW; van de Veerdonk FL; Netea MG
    Clin Exp Immunol; 2015 Sep; 181(3):434-40. PubMed ID: 25880788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased IL-17A secretion in response to Candida albicans in autoimmune polyendocrine syndrome type 1 and its animal model.
    Ahlgren KM; Moretti S; Lundgren BA; Karlsson I; Ahlin E; Norling A; Hallgren A; Perheentupa J; Gustafsson J; Rorsman F; Crewther PE; Rönnelid J; Bensing S; Scott HS; Kämpe O; Romani L; Lobell A
    Eur J Immunol; 2011 Jan; 41(1):235-45. PubMed ID: 21182094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis.
    Boisson B; Wang C; Pedergnana V; Wu L; Cypowyj S; Rybojad M; Belkadi A; Picard C; Abel L; Fieschi C; Puel A; Li X; Casanova JL
    Immunity; 2013 Oct; 39(4):676-86. PubMed ID: 24120361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC).
    Zheng J; van de Veerdonk FL; Crossland KL; Smeekens SP; Chan CM; Al Shehri T; Abinun M; Gennery AR; Mann J; Lendrem DW; Netea MG; Rowan AD; Lilic D
    Eur J Immunol; 2015 Oct; 45(10):2834-46. PubMed ID: 26255980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered Immune Activation and IL-23 Signaling in Response to
    Bruserud Ø; Bratland E; Hellesen A; Delaleu N; Reikvam H; Oftedal BE; Wolff ASB
    Front Immunol; 2017; 8():1074. PubMed ID: 28919897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inherited CARD9 Deficiency: Invasive Disease Caused by Ascomycete Fungi in Previously Healthy Children and Adults.
    Corvilain E; Casanova JL; Puel A
    J Clin Immunol; 2018 Aug; 38(6):656-693. PubMed ID: 30136218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HDAC inhibitors modulate innate immune responses to micro-organisms relevant to chronic mucocutaneous candidiasis.
    Rösler B; Wang X; Keating ST; Joosten LAB; Netea MG; van de Veerdonk FL
    Clin Exp Immunol; 2018 Nov; 194(2):205-219. PubMed ID: 30069986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired dendritic cell maturation and cytokine production in patients with chronic mucocutanous candidiasis with or without APECED.
    Ryan KR; Hong M; Arkwright PD; Gennery AR; Costigan C; Dominguez M; Denning D; McConnell V; Cant AJ; Abinun M; Spickett GP; Lilic D
    Clin Exp Immunol; 2008 Dec; 154(3):406-14. PubMed ID: 19037923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.